Physician profile
Patrick T Paw
NPI 1306946793
$533.27
in general payments reported to CMS, 2019-2025
9 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.42 · 2021: $69.14 · 2022: $23.03 · 2023: $158 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $202.89 | 2023-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Lemaitre Vascular, INC. | $51.87 | 2023-2025 | Restoreflow, Cardiocel, Xenosure Biologic Patch |
| Edwards Lifesciences Corporation | $51.12 | 2025 | |
| Abbott Laboratories | $48.18 | 2025 | Epic, 2nd Gen Centrimag Primary Console |
| Abiomed | $47.55 | 2021 | |
| Angiodynamics, INC. | $45.02 | 2022-2023 | Alphavac |
| Ethicon US, LLC | $35.01 | 2019-2021 | |
| Kls-Martin L.P. | $29.07 | 2025 | |
| Becton, Dickinson and Company | $22.56 | 2025 | Progel Applicator Spray Tips |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Paw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.